Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorAndrew Catanzaro, Barney S. Graham, Mary E. Enama et al.|The Journal of Infectious Diseases|2006Cited by 318
Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody <i>In Vitro</i> Improves Protection against Lentiviral Infection <i>In Vivo</i>Rebecca S. Rudicell, Gary J. Nabel, Young Do Kwon et al.|Journal of Virology|2014Cited by 294